Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06785337 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

"The Effect of Inhaled Nitroglycerin for COPD Patients

Study acronym: iNGCOPD
StatusRecruiting
PhasePhase 2/3
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated January 23, 2025 (before its estimated October 1, 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Secondary endpoints revised (4)
    • Site contact updated
    • Publications: details revised at 8 of 8 entries
    v2
  2. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
1,119 trials monitored
See 34 trials at risk
this study aims to investigative the benefits of using nebulized nitroglycerin in improving respiratory functions in patients of late stage COPD
Trial Details
NCT Number NCT06785337
Lead Sponsor Beni-Suef University
Conditions
(from sponsor)
COPD, COPD III/IV
Related terms Pulmonary Disease, Chronic Obstructive, Respiratory Aspiration
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov